-
Genotype data for The admixture histories of Cabo Verde - genotype data
Dataset
EGAD00001008979
-
Genomic profiling of BRCA- mutant breast cancer tumors
Dataset
EGAD00001008276
-
Blueprint: A human variation panel of genetic influences on epigenomes and transcriptomes in three immune cell types, (RNA-Seq for CD4-positive, alpha-beta T cell, on genome GRCh37)
Dataset
EGAD00001002671
-
BLUEPRINT release August 2016, RNA-Seq for CD34-negative, CD41-positive, CD42-positive megakaryocyte cell, on genome GRCh38
Dataset
EGAD00001002339
-
BLUEPRINT release August 2014, RNA-Seq for CD34-negative, CD41-positive, CD42-positive megakaryocyte cell
Dataset
EGAD00001000903
-
BLUEPRINT release January 2015, RNA-Seq for CD34-negative, CD41-positive, CD42-positive megakaryocyte cell
Dataset
EGAD00001001165
-
BLUEPRINT release August 2015, RNA-Seq for CD34-negative, CD41-positive, CD42-positive megakaryocyte cell, on genome GRCh38
Dataset
EGAD00001001534
-
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer
Dataset
EGAD00001011991
-
CCA RNA-seq data (60 CCA, 6 normal, 16 cell-line)
Dataset
EGAD00001011998
-
A108837A
Dataset
EGAD00001007090
-
A108846A
Dataset
EGAD00001007091
-
Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment
Study
EGAS50000001619
-
Prospective Lynch Syndrome Database materials
Study
EGAS50000001715
-
Imputed_genetics
Dataset
EGAD00010001544
-
mtDNA-Roma
Dataset
EGAD00010001844
-
Gene Expression Profiling for study EGAS00001004165
Dataset
EGAD00010001842
-
Sequencing data for oesophageal and related samples - OACs release 1 (RNA)
Dataset
EGAD00001002259
-
Illumina BeadArray SNP arrays
Dataset
EGAD00010002137
-
INMUNGEN_CoV2_genotype
Dataset
EGAD00010002174
-
Converging and evolving immuno-genomic routes towards immune escape in breast cancer
Dac
EGAC50000000074
-
Biomarker Data from KATHERINE: A Phase III Study of Adjuvant Trastuzumab Emtansine versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer
Study
EGAS00001006229
-
GEOCODE Cohort
Dataset
EGAD50000001320
-
scWGS primaries
Dataset
EGAD00001006138
-
Follicular T cell lymphoma
Dataset
EGAD00001006379
-
RNAseq BAM files
Dataset
EGAD00001006268